UHS earnings analysis
What we found in UHS's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
UHS delivered solid Q2 operating growth, with revenue of $4.638 billion and diluted EPS of $5.98, up 8.4% and 10.1% year over year, respectively. Operating income increased to $516.7 million, but operating margin declined to approximately 11.1% from 11.7% in the prior-year quarter. The 10-Q introduces material execution and regulatory risks related to the approximately $835 million Talkspace acquisition and the District of Columbia physician transaction, while providing no new quantitative guidance.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue growth accelerated
- Second-quarter revenue was $4.638 billion, up approximately 3.1% from $4.5 billion in Q1 2026 and 8.4% from $4.28 billion in Q2 2025.
- EPS increased sequentially and year over year
- Diluted EPS was $5.98, versus $5.65 in Q1 2026 and $5.43 in Q2 2025, representing sequential growth of approximately 5.8% and year-over-year growth of 10.1%.
- Operating income rose, margin contracted
- Operating income increased to $516.7 million from $500.3 million in the prior-year quarter. Based on reported revenue, operating margin was approximately 11.1%, down from 11.7% in Q2 2025.
- Significant share repurchases
- UHS repurchased 1,890,298 shares for an aggregate purchase price of approximately $320.3 million during Q2 2026, at an average price of $169.43 per share.
- Talkspace acquisition advances
- UHS agreed to acquire Talkspace for $5.25 per share, or approximately $835 million in aggregate. Talkspace has approximately 6,000 licensed professionals serving all 50 states, Washington, D.C., and Puerto Rico, and closing is expected during Q3 2026.
- Quarterly dividend maintained
- The company declared and paid a quarterly dividend of $0.20 per share during the quarter ended June 30, 2026.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Talkspace execution and financing risk
- The approximately $835 million Talkspace acquisition is subject to regulatory approvals and customary closing conditions, with closing expected in Q3 2026. The filing identifies integration, financing, provider retention and synergy-realization risks.
- District Hospitals regulatory review
- The District of Columbia Office of the Attorney General is reviewing the physician-management transaction involving George Washington University Hospital and Cedar Hill Regional Medical Center; the review is expected to be completed by the end of Q3 2026. If the transaction is rejected or materially changed, it may need to be unwound and could materially affect District Hospitals' results.
- Physician retention pressure
- The filing adds or updates physician recruitment and retention risks, noting that physicians may terminate affiliations at any time and that the loss of one or more physicians could cause a material reduction in revenue.
- Higher capital and borrowing needs
- UHS repurchased approximately $320.3 million of stock in Q2 2026 while also intending to finance the approximately $835 million Talkspace acquisition with additional borrowings under its Credit Agreement, increasing capital-allocation and leverage sensitivity.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $5.98
- Operating margin
- 11.1%
What they said about what is next.
The 10-Q does not provide new quantitative revenue or EPS guidance. The prior 8-K disclosed FY2026 revenue guidance of $18.501 billion-$18.762 billion and adjusted diluted EPS guidance of $22.28-$23.65, but no updated outlook was included in this filing.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 7, 2026
- Universal Health Services (UHS) reported a strong performance for Q1 2026, with revenues at $4.495 billion, marking a 9.6% increase year-over-year. The company's diluted EPS of $5.62 exceeded estimates, reflecting…
- 10-K · February 25, 2026
- Universal Health Services (UHS) emphasizes growth through selective acquisitions, expansion of outpatient services and operational improvements while operating 375 inpatient and 168 outpatient/other facilities as of…
- 10-Q · November 7, 2025
- Universal Health Services reported Q3 2025 net revenues of $4,495,245 (thousands), up versus Q3 2024 $3,963,027 (thousands) (+~13.4% YoY), and diluted EPS attributable to UHS of $5.86 (Q3 2025) versus $3.80 (Q3 2024).…
- 10-Q · November 8, 2024
- UHS reported Q3 net revenues of $3,963,027 (thousands), up 11.3% year-over-year from $3,562,774 and up modestly sequentially vs. Q2 2024 ($3.91B). Income from operations rose to $384,165 (thousands) and diluted EPS was…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing UHS makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever